1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

New Drug Could Treat Brain Injury, Alzheimer's, Multiple Sclerosis

By profesor, Jul 29, 2012 | | |
  1. profesor
    A new class of drug developed at Northwestern University Feinberg School of Medicine shows early promise of being a one-size-fits-all therapy for Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain.
    Northwestern has recently been issued patents to cover this new drug class and has licensed the commercial development to a biotech company that has recently completed the first human Phase 1 clinical trial for the drug.
    The drugs in this class target a particular type of brain inflammation, which is a common denominator in these neurological diseases and in traumatic brain injury and stroke. This brain inflammation, also called neuroinflammation, is increasingly believed to play a major role in the progressive damage characteristic of these chronic diseases and brain injuries.
    By addressing brain inflammation, the new class of drugs -- represented by MW151 and MW189 -- offers an entirely different therapeutic approach to Alzheimer's than current ones being tested to prevent the development of beta amyloid plaques in the brain. The plaques are an indicator of the disease but not a proven cause. - ScienceDaily (July 24, 2012)


    http://www.sciencedaily.com/releases/2012/07/120724171302.htm

Comments

  1. Alfa
  2. stryder09
    As Alfa stated, what types of drugs are these? I cannot find any specific info. I'd hate to think the research/trials would be made more difficult due to the recent cannabinoid/ synthetic law.
  3. Fentiful
  4. ThirdEyeFloond
  5. Fentiful
    " In addition, morphine-induced elevations in proinflammatory cytokines can cause acute opioid tolerance and withdrawal-induced pain enhancement after chronic morphine (Watkins, L. R. et al., Trends Neurosci. 2005, 28, 661-669)."

    Interesting.
  6. markbrook
    Well what I understand in this post they are researching on a medicine which will be helpful in brain mental treatment as I research on natural herbals so I need more search on this new drug.
  7. C11H15
    I think it is kept quiet so it cannot be replicated. Although it is interesting that they don't even reveal the name of the 'new' class.
    I will be keeping an eye on this one, hopefully it will help alot of people.
To make a comment simply sign up and become a member!